Back
Perrigo Co PLC 10K Form
Sell
37
PRGO
Perrigo Co PLC
Last Price:
26.72
Seasonality Move:
1.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | PRGO/Perrigo Co PLC Quarterly |
2023-11-07 | 10Q | PRGO/Perrigo Co PLC Quarterly |
2023-08-08 | 10Q | PRGO/Perrigo Co PLC Quarterly |
2023-05-09 | 10Q | PRGO/Perrigo Co PLC Quarterly |
2022-11-08 | 10Q | PRGO/Perrigo Co PLC Quarterly |
2022-08-09 | 10Q | PRGO/Perrigo Co PLC Quarterly |
Receive PRGO News And Ratings
See the #1 stock for the next 7 days that we like better than PRGO
PRGO Financial Statistics
Sales & Book Value
Annual Sales: | $4.66B |
---|---|
Cash Flow: | $15.1M |
Price / Cash Flow: | 23.81 |
Annual Sales: | $33.45 |
Price / Book: | 0.79 |
Profitability
EPS (TTM): | -1.17000 |
---|---|
Net Income (TTM): | $-159.7M |
Gross Margin: | $1.68B |
Return on Equity: | -3.43% |
Return on Assets: | -1.48% |
Perrigo Co PLC Earnings Forecast
Key Perrigo Co PLC Financial Ratios
- The Gross Profit Margin over the past 32 years for PRGO is 36.09%.
- The Selling, General & Administrative Expenses for PRGO have been equal to 27.38% of Gross Profit Margin.
- The Research & Development expenses have been 2.63% of Revenue.
- The Interest Expense is -1,368.50% of Operating Income.
- The Net Earning history of PRGO is -0.27% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 22 years.
Perrigo Co PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | PRGO |
CUSIP: | G97822 |
Website: | perrigo.com |
Debt
Debt-to-Equity Ratio: | 1.04 |
---|---|
Current Ratio: | 2.56 |
Quick Ratio: | 1.55 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 8.45 |
PRGO Technical Analysis vs Fundamental Analysis
Sell
37
Perrigo Co PLC (PRGO)
is a Sell
Is Perrigo Co PLC a Buy or a Sell?
-
Perrigo Co PLC stock is rated a Sell
The current Perrigo Co PLC [PRGO] share price is $26.81. The Score for PRGO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.